Nexien Biopharma (NXEN) Short Interest Ratio & Short Volume $0.01 +0.01 (+821.43%) As of 08/28/2025 03:54 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartSEC FilingsShort InterestBuy This Stock Nexien Biopharma Short Interest DataNexien Biopharma (NXEN) has a short interest of 500 shares, representing 0.00% of the float (the number of shares available for trading by the public). This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 24 shares to cover all short positions.Current Short Interest500 sharesPrevious Short Interest500 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$2.85Short Interest Ratio0.0 Days to CoverLast Record DateJune 15, 2025Outstanding Shares70,770,000 sharesShort Percent of Float0.00%Today's Trading Volume751 sharesAverage Trading Volume24 sharesToday's Volume Vs. Average3,123% Short Selling Nexien Biopharma? Sign up to receive the latest short interest report for Nexien Biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNXEN Short Interest Over TimeNXEN Days to Cover Over TimeNXEN Percentage of Float Shorted Over Time Nexien Biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/2025500 shares $2.85 No Change0.0%0 $0.01 5/31/2025500 shares $4.75 No Change0.0%0.1 $0.01 5/15/2025500 shares $4.85 No Change0.0%0.1 $0.01 4/30/2025500 shares $4.75 No ChangeN/A0 $0.01 4/15/2025500 shares $4.50 No Change0.0%0.2 $0.01 3/31/2025500 shares $4.50 No Change0.0%0.1 $0.01 3/15/2025500 shares $7.00 No Change0.0%0.1 $0.01 2/28/2025500 shares $3.60 No Change0.0%0.1 $0.01 2/15/2025500 shares $3.50 No Change0.0%0 $0.01 1/31/2025500 shares $3.00 No ChangeN/A0.1 $0.01 Get the Latest News and Ratings for NXEN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nexien Biopharma and its competitors with MarketBeat's FREE daily newsletter. 1/15/2025500 shares $5.45 No ChangeN/A0 $0.01 12/31/2024500 shares $2.80 No ChangeN/A0 $0.01 12/15/2024500 shares $2.75 No ChangeN/A0 $0.01 11/30/2024500 shares $7.05 No ChangeN/A0 $0.01 11/15/2024500 shares $6.50 -16.7%N/A0 $0.01 10/31/2024600 shares $28.20 -83.8%N/A0 $0.05 10/15/20243,700 shares $71.41 +516.7%N/A0.1 $0.02 9/30/2024600 shares $10.44 -25.0%N/A0 $0.02 9/15/2024800 shares $13.92 No ChangeN/A0 $0.02 8/31/2024800 shares $13.92 No ChangeN/A0 $0.02 8/15/2024800 shares $14.40 No ChangeN/A0.1 $0.02 7/31/2024800 shares $15.66 -96.9%N/A0 $0.02 7/15/202425,700 shares $452.32 No ChangeN/A2 $0.02 6/30/202425,700 shares $434.33 No ChangeN/A2.4 $0.02 6/15/202425,700 shares $543.30 -11.1%N/A1.9 $0.02 5/31/202428,900 shares $590.95 No ChangeN/A1.3 $0.02 5/15/202428,900 shares $606.90 No ChangeN/A0.9 $0.02 4/30/202428,900 shares $476.85 No ChangeN/A2.1 $0.02 4/15/202428,900 shares $838.10 +28,800.0%N/A1.3 $0.03 3/31/2024100 shares $1.63 No ChangeN/A0 $0.02 3/15/2024100 shares $1.63 No ChangeN/A0 $0.02 11/15/2023100 shares $2.50 -80.0%N/A0 $0.03 10/31/2023500 shares $11.50 +400.0%N/A0.1 $0.02 10/15/2023100 shares $2.88 No ChangeN/A0 $0.03 4/15/2023300 shares $8.99 No ChangeN/A0 $0.03 3/31/2023300 shares $8.99 No ChangeN/A0.1 $0.03 3/15/2023300 shares $10.74 No ChangeN/A0 $0.04 10/31/20225,300 shares $265.00 No ChangeN/A0.3 $0.05 10/15/20225,300 shares $249.31 -15.9%N/A0.2 $0.05 9/30/20226,300 shares $415.80 No ChangeN/A0.7 $0.07Altucher: It Looks Like My Trump prediction is coming true (Ad)New Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Trump’s Great Gain” has officially begun. Altucher believes select cryptos could turn $900 into $108,000 over the next 12 months — and he’s laying out the full gameplan in a new presentation.See Altucher’s Trump crypto prediction here 9/15/20226,300 shares $418.95 -55.9%N/A0.5 $0.07 8/31/202214,300 shares $1.43 thousand No ChangeN/A2.5 $0.10 8/15/202214,300 shares $936.65 +24.4%N/A0.7 $0.07 7/31/202211,500 shares $730.25 No ChangeN/A2.5 $0.06 7/15/202211,500 shares $787.75 No ChangeN/A1.6 $0.07 6/30/202211,500 shares $718.75 No ChangeN/A2 $0.06 6/15/202211,500 shares $747.50 +11,400.0%N/A0.9 $0.07 5/31/2022100 shares $7.43 No ChangeN/A0 $0.07 3/31/20226,900 shares $276.00 No ChangeN/A0.6 $0.04 3/15/20226,900 shares $242.19 -4.2%N/A1.2 $0.04 2/28/20227,200 shares $352.80 No ChangeN/A0.8 $0.05 2/15/20227,200 shares $295.20 +2.9%N/A0.9 $0.04 1/31/20227,000 shares $350.00 +37.3%N/A0.4 $0.05 1/15/20225,100 shares $305.49 No ChangeN/A0.1 $0.06 10/15/2021100 shares $8.18 No ChangeN/A0 $0.08 9/15/2021100 shares $9.99 -50.0%N/A0 $0.10 8/31/2021200 shares $12.52 -33.3%N/A0 $0.06 8/13/2021300 shares $21.00 No ChangeN/A0 $0.07 7/15/20218,500 shares $684.25 No ChangeN/A0.1 $0.08 6/15/20212,500 shares $250.00 +66.7%N/A0.1 $0.10 5/28/20211,500 shares $147.75 +114.3%N/A0.1 $0.10 5/14/2021700 shares $57.40 No ChangeN/A0 $0.08 3/31/2021200 shares $20.00 No ChangeN/A0 $0.10 3/15/2021200 shares $32.80 -94.9%N/A0 $0.16 2/26/20213,900 shares $585.00 -44.3%N/A0 $0.15 2/12/20217,000 shares $1.06 thousand +55.6%N/A0.1 $0.15 1/29/20214,500 shares $472.50 +50.0%N/A0.1 $0.11 1/15/202132,600 shares $3.59 thousand +1,024.1%N/A0.4 $0.11 12/31/2020600 shares $54.00 -98.2%N/A0 $0.09 12/15/202032,600 shares $3.09 thousand +1,024.1%N/A0.4 $0.09 11/30/20202,900 shares $145.00 No ChangeN/A0 $0.05 10/30/20201,400 shares $82.60 +7.7%N/A0 $0.06 10/15/20201,300 shares $84.50 No ChangeN/A0 $0.07 NXEN Short Interest - Frequently Asked Questions What is Nexien Biopharma's current short interest? Short interest is the volume of Nexien Biopharma shares that have been sold short but have not yet been closed out or covered. As of June 15th, traders have sold 500 shares of NXEN short. 0.00% of Nexien Biopharma's shares are currently sold short. Learn More on Nexien Biopharma's current short interest. What is a good short interest percentage for Nexien Biopharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.00% of Nexien Biopharma's floating shares are currently sold short. How does Nexien Biopharma's short interest compare to its competitors? 0.00% of Nexien Biopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Nexien Biopharma: Viracta Therapeutics, Inc. (0.04%), Trevena, Inc. (0.61%), Bon Natural Life Limited (66.10%), Vincerx Pharma, Inc. (0.05%), Capstone Holding Corp. (0.11%), Omega Therapeutics, Inc. (0.65%), GlobeStar Therapeutics Corporation (0.00%), NuCana PLC Sponsored ADR (290.48%), Propanc Biopharma Inc (11.05%), Neptune Wellness Solutions Inc. (1.18%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), Strategy Inc ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short Nexien Biopharma stock? Short selling NXEN is an investing strategy that aims to generate trading profit from Nexien Biopharma as its price is falling. NXEN shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Nexien Biopharma? A short squeeze for Nexien Biopharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NXEN, which in turn drives the price of the stock up even further. How often is Nexien Biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NXEN, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies VIRX Short Squeeze TRVN Short Squeeze BON Short Squeeze VINC Short Squeeze CAPS Short Squeeze OMGAQ Short Squeeze GSTC Short Squeeze NCNA Short Squeeze PPCB Short Squeeze NEPTF Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:NXEN) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nexien Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nexien Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access